Efavirenz-induced neurological symptoms in rare homozygote CYP2B6*2/*2 (C64T)

被引:8
作者
Usami, Osamu
Ashino, Yugo
Komaki, Yuichi
Tomaki, Masafurni
Irokawa, Toshiya
Tamada, Tsutornu
Hayashida, Tsunefusa
Teruya, Katsuji
Hattori, Toshio
机构
[1] Tohoku Univ, Div Infect & Resp Dis, Aoba Ku, Sendai, Miyagi 980, Japan
[2] Int Med Ctr Japan, AIDS Clin Ctr, Tokyo, Japan
关键词
polymorphism; SNP; HIV; HAART; Japan; REVERSE-TRANSCRIPTASE INHIBITOR; CYTOCHROME P4502B6 GENE; ALLELE FREQUENCIES; CYP2B6; METABOLISM; PHARMACOKINETICS; VARIABILITY; THERAPY;
D O I
10.1258/095646207781439810
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Some of the HIV-1 -infected patients who were given highly active anti-retroviral therapy (HAART) including efavirenz (EFV) presented adverse central nervous system (CNS) symptoms such as fatigue and insomnia. The incidence of adverse CNS symptoms is associated with hepatic cytochrome P450 isozymes (CYP2B6) polymorphisms. For example, CYP2B6 *6 (G516T and A785G) and *7 (G516T, A785G and C1459T) prolonged the EFV half-life despite discontinuation of EFV. CYP2B6 *2/*2 (C641) is extremely rare and there have been no data describing the EFV plasma concentrations in C64T homozygous patients, who developed adverse CNS symptoms. C64T homozygous possibly has some catalytic defects.
引用
收藏
页码:575 / 576
页数:2
相关论文
共 50 条
[21]   Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV Infection [J].
Meng, Xianmin ;
Yin, Kang ;
Wang, Jiangrong ;
Dong, Ping ;
Liu, Li ;
Shen, Yinzhong ;
Shen, Li ;
Ma, Qing ;
Lu, Hongzhou ;
Cai, Weimin .
PLOS ONE, 2015, 10 (06)
[22]   Influence of CYP2B6 and CYP3A4 polymorphisms on the virologic and immunologic responses of patients treated with efavirenz-containing regimen [J].
Kassogue, Yaya ;
Diakite, Brehima ;
Maiga, Mamoudou ;
Kassogue, Oumar ;
Konate, Issa ;
Tamboura, Kadidiatou ;
Diarra, Fousseyni ;
Diarra, Zoumana ;
Sawadogo, Mahamadou Karamoko ;
Goita, Yaya ;
Sissoko, Sidi Boula ;
Sissoko, Adama Seydou ;
Guirou, Nouhoum ;
Dehbi, Hind ;
Nadifi, Sellama ;
Bah, Sekou ;
Traore, Cheick Bougadari ;
Kamate, Bakarou ;
Dao, Sounkalo ;
Dolo, Guimogo .
PHARMACOGENETICS AND GENOMICS, 2022, 32 (06) :219-225
[23]   CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women [J].
Roehrich, Carola R. ;
Droegemoeller, Britt I. ;
Ikediobi, Ogechi ;
van der Merwe, Lize ;
Grobbelaar, Nelis ;
Wright, Galen E. B. ;
McGregor, Nathaniel ;
Warnich, Louise .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (06) :529-538
[24]   Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics [J].
Saiz-Rodriguez, Miriam ;
Ochoa, Dolores ;
Roman, Manuel ;
Zubiaur, Pablo ;
Koller, Dora ;
Mejia, Gina ;
Abad-Santos, Francisco .
PHARMACOGENOMICS, 2020, 21 (10) :663-675
[25]   CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe [J].
Dhoro, Milcah ;
Zvada, Simbarashe ;
Ngara, Bernard ;
Nhachi, Charles ;
Kadzirange, Gerald ;
Chonzi, Prosper ;
Masimirembwa, Collen .
BMC PHARMACOLOGY & TOXICOLOGY, 2015, 16
[26]   CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz [J].
Griesel, Rulan ;
Maartens, Gary ;
Chirehwa, Maxwell ;
Sokhela, Simiso ;
Akpomiemie, Godspower ;
Moorhouse, Michelle ;
Venter, Francois ;
Sinxadi, Phumla .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) :E3902-E3909
[27]   Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial [J].
Gallien, S. ;
Journot, V. ;
Loriot, M-A ;
Sauvageon, H. ;
Morlat, P. ;
Reynes, J. ;
Reliquet, V. ;
Chene, G. ;
Molina, J-M .
HIV MEDICINE, 2017, 18 (08) :537-545
[28]   Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 alleles [J].
Gonzalo Restrepo, Juan ;
Martinez, Carmen ;
Garcia-Agundez, Augusto ;
Gaviria, Elmer ;
Julio Laguna, Jose ;
Garcia-Martin, Elena ;
Agundez, Jose A. G. .
PHARMACOGENETICS AND GENOMICS, 2011, 21 (12) :773-778
[29]   Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism [J].
Sukasem, C. ;
Manosuthi, W. ;
Koomdee, N. ;
Santon, S. ;
Jantararoungtong, T. ;
Prommas, S. ;
Chamnanphol, M. ;
Puangpetch, A. ;
Sungkanuparph, S. .
INFECTION, 2014, 42 (03) :469-474
[30]   Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism [J].
C. Sukasem ;
W. Manosuthi ;
N. Koomdee ;
S. Santon ;
T. Jantararoungtong ;
S. Prommas ;
M. Chamnanphol ;
A. Puangpetch ;
S. Sungkanuparph .
Infection, 2014, 42 :469-474